We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Licenses Vanderbilt University’s Monoclonal Antibodies for COVID-19
AstraZeneca Licenses Vanderbilt University’s Monoclonal Antibodies for COVID-19
AstraZeneca has licensed six monoclonal antibodies from Vanderbilt University and plans to advance the most promising ones for prevention and treatment of COVID-19.